Feed items

Late on a chilly Friday in February 2013, Novo Nordisk A/S Chief Executive Officer Lars Rebien Soerensen got news that his company’s most promising new treatment, an insulin called Tresiba, had been rejected by U.S. regulators.

Hours after we closed on our first house, my husband and I sat in our empty new living room and stared at the walls. He was the first to speak, saying simply, “I thought it was painted.” We learned a lot about that old house over the next 15 years, and while we knew to expect some changes, others, such as the need to paint the walls, we would figure out as we went along. That included making some adjustments to our tax forms. All of those ...

Fox News Legal Analysts Lis Wiehl and Mercedes Colwin on a lawsuit against the city of Seattle and a football coach under investigation for post-game prayers.

Sept. 16 -- College textbook prices are on the rise, but several new startups, websites and initiatives are helping students to hit the books without breaking the bank. Bloomberg's Willem Marx has the story.